Pharmaceutical Treatment Vs. Lifestyle Modification

Decent Essays
Introduction Cardiovascular disease remains the leading cause of death, outranking cancer in the United States, according to the data from CDC National Center for Health Statistics. The American College of Cardiology/American Heart Association (ACC/AHA) periodically publishes guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. However, the 2013 ACC/AHA Guideline has still not gained multinational acceptance among providers (Stone, 2014). Pharmaceutical treatment versus lifestyle modification has been a controversy among the scientific community (Sinatra, 2014). Provider adherence to the 2013 ACC/AHA Cholesterol Guideline in order to achieve universal standard of care remains a challenge. The recent guideline represents a major shift from prior cholesterol management, as it`s primary focus is on the role of cholesterol treatment in atherosclerotic cardiovascular disease (ASCVD) risk reduction versus a comprehensive approach to lipid management (Finkel, 2015). Major independent positive risk factors for coronary artery disease, such as age, family history of premature coronary artery disease, hypertension, tobacco use, diabetes mellitus, elevated total cholesterol and low-density lipoprotein, are now well recognized. Therefore, prevention of heart disease by applying lifestyle modification or pharmaceutical management should be a major goal of all primary care providers. Nurse Practitioners are in a prime position to
Get Access